Attached files
file | filename |
---|---|
EX-32.1 - EX-32.1 - Adverum Biotechnologies, Inc. | advm-ex321_8.htm |
EX-31.2 - EX-31.2 - Adverum Biotechnologies, Inc. | advm-ex312_6.htm |
EX-31.1 - EX-31.1 - Adverum Biotechnologies, Inc. | advm-ex311_7.htm |
10-Q - 10-Q - Adverum Biotechnologies, Inc. | advm-10q_20170930.htm |
Exhibit 12.1
STATEMENT OF COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
(Dollars in thousands)
|
|
Nine Months |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ended September 30, |
|
|
Year Ended December 31, |
|
||||||||||
|
|
2017 |
|
|
2016 |
|
|
2015 |
|
|
2014 |
|
||||
Fixed charges: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense on indebtedness |
|
$ |
20 |
|
|
$ |
25 |
|
|
$ |
14 |
|
|
$ |
0 |
|
Interest expense on portion of rent expense representative of interest |
|
$ |
94 |
|
|
$ |
122 |
|
|
$ |
92 |
|
|
$ |
18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed charges |
|
$ |
114 |
|
|
$ |
147 |
|
|
$ |
106 |
|
|
$ |
18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock deemed dividend |
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
3,230 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed charges and preferred dividend |
|
$ |
114 |
|
|
$ |
147 |
|
|
$ |
106 |
|
|
$ |
3,248 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(41,358 |
) |
|
$ |
(114,522 |
) |
|
$ |
(47,453 |
) |
|
$ |
(25,404 |
) |
Fixed charges per above |
|
$ |
114 |
|
|
$ |
147 |
|
|
$ |
106 |
|
|
$ |
18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total earnings (loss) |
|
$ |
(41,244 |
) |
|
$ |
(114,375 |
) |
|
$ |
(47,347 |
) |
|
$ |
(25,386 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ratio of earnings to fixed charges |
|
N/A |
|
|
N/A |
|
|
N/A |
|
|
N/A |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deficiency of earnings available to cover fixed charges |
|
$ |
(41,358 |
) |
|
$ |
(114,522 |
) |
|
$ |
(47,453 |
) |
|
$ |
(28,634 |
) |